2nd Quarter - Report

THE RABEN GROUP for AMGEN U.S.A. INC

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Lobbying in support of The Pathways for Biologics Act (HR1548), to promote patient safety while supporting the development of biologics, and related Senate legislation.

LobbyistCovered position, as disclosed
LICY DO CANTO —
LAWRENCE FRANCISCO GONZALEZ —
MEAGHAN FRANCES HOHL Legis. Aide Sen. Kerry; Legis. Asst. Congr Watson
ROBERT RABEN Asst. Attorney Gen, DOJ; Counsel House Judiciary

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.